On Thursday morning, we learned that a set of popular and expensive prescription drugs will soon cost less under Medicare. The Biden Administration announced that Medicare had walked away from its first negotiations with drug companies with discounts between 38 and 79 percent.

The state of Minnesota also has a new board created to bring down the cost of some drugs. Jessica Intermill is one of the patient representatives on the board’s advisory council. And she’s testified before the state legislature about the impacts of expensive treatments for rheumatoid arthritis on her own life.

She joined MPR News host Cathy Wurzer to share the impacts of the lower drug costs for people like her.